0      0

EU24CEMAR1/SES110 - Cell Therapy: BMS’s Value Stream Transformation

‐ Mar 13, 2024 11:55am

Traditionally, delivery of cell therapy medicine to patients in need is comprised of inefficient, siloed functional groups whereby processing activities and departmental handoffs impede delivery.  BMS in Summit, NJ USA, the first location to produce 2 commercially-approved cell therapy products, underwent a transformative organizational structure change into a Value Stream approach.  This presentation will cover how expeditious product turnaround times were significantly improved and sustained.